GGrantIndex
← Leaderboards

Healthpartners Institute

Minneapolis, MN

Compare ↔
$152,773,324
Total funding
77
Grants

Funding over time

peak $16.6M · FY2006–25
$20M$15M$10M$5M$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$142,233,912 · 67
AHRQ$6,790,689 · 6
CDC$2,753,613 · 3
NSF$995,110 · 1

By mechanism

R01$69,579,510 · 31
UG1$34,847,423 · 1
R18$11,839,644 · 8
U01$10,036,792 · 5
UC4$8,930,305 · 1
R21$4,731,155 · 11

Investigators at Healthpartners Institute

Investigator-initiatedAll funding

InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).

Rising Stars

First grant in the last 5 yrs

1Michael V Maciosek$2,344,6191 gr

Emerging Leaders

6–10 yrs in

1Leah R Hanson$2,607,0612 gr2Catherine Pastorius Benziger$997,8851 gr3Kathryn A Wyman-Chick$440,8901 gr4Stephanie A Hooker$437,2501 gr5A Lauren Crain$388,2861 gr6Jeffrey Paul Anderson$154,0001 gr

All-Time

Most funded here, all years

1Joann M Sperl-Hillen$7,375,2364 gr2Nancy E Sherwood$6,848,2135 gr3Alicia S Kunin-Batson$6,483,2714 gr4Leif I Solberg$5,736,8133 gr5Elyse Olshen Kharbanda$5,478,2613 gr6Bjorn Christopher Westgard$5,097,5022 gr7Jay R Desai$3,339,5081 gr8Thomas Edward Elliott$3,019,8041 gr

Largest grants

Home Use of MD-Logic Automated Insulin Delivery System: Safety and Efficacy$6,938,637
UC4 · FY2016 · DK
Metro-Minnesota Community Oncology Research Consortium (MMCORC)$4,075,539
UG1 · FY2025 · CA
Metro-Minnesota Community Oncology Research Consortium (MMCORC)$4,033,630
UG1 · FY2022 · CA
Metro-Minnesota Community Oncology Research Consortium (MMCORC)$3,913,879
UG1 · FY2023 · CA
Metro-Minnesota Community Oncology Research Consortium (MMCORC)$3,879,257
UG1 · FY2024 · CA
Metro-Minnesota Community Oncology Research Consortium (MMCORC)$3,864,540
UG1 · FY2021 · CA
Metro-Minnesota Community Oncology Research Consortium (MMCORC)$3,618,492
UG1 · FY2020 · CA
Metro-Minnesota Community Oncology Research Consortium (MMCORC)$3,274,239
UG1 · FY2019 · CA
Metro-Minnesota Community Clinical Oncology Program (MM-CCOP)$2,840,966
UG1 · FY2018 · CA
Metro-Minnesota Community Clinical Oncology Program (MM-CCOP)$2,680,381
UG1 · FY2017 · CA
Metro-Minnesota Community Clinical Oncology Program (MM-CCOP)$2,580,000
UG1 · FY2016 · CA
Mitigating Diabetic Ketoacidosis in People with T1D and Chronic Kidney Disease on an SGLT1&2 Inhibitor: Ketosis Risk Factor Determination and Incorporation into an Enhanced Glucose Ketone Report$2,352,906
U01 · FY2025 · DK
Home Use of MD-Logic Automated Insulin Delivery System: Safety and Efficacy$1,991,668
UC4 · FY2015 · DK
A Technology-Driven Intervention to Improve Early Detection and Management of Cognitive Impairment$1,455,139
R33 · FY2024 · AG
A Technology-Driven Intervention to Improve Early Detection and Management of Cognitive Impairment$1,200,487
R33 · FY2022 · AG
A Technology-Driven Intervention to Improve Early Detection and Management of Cognitive Impairment$1,148,058
R33 · FY2023 · AG
SCISIPBIO: Constructing Heterogeneous Scholarly Graphs to Examine Social Capital During Mentored K Awardees Transition to Research Independence: Explicating a Matthew Mechanism$995,110
· FY2021 · SBE
CV Benefits and Safety of Glucose-Lowering Therapies in Adults with Diabetes$818,099
R01 · FY2014 · HL
De-Implementing Opioid Use and Implementing Optimal Pain Management Following Dental Extractions$785,139
U01 · FY2017 · DE
Reducing CV Risk in Prediabetes Patients Using EHR-Based Decision Support$774,716
R01 · FY2015 · HL